Literature DB >> 17046693

Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins.

Guillermo M Elias1, Lars Funke, Valentin Stein, Seth G Grant, David S Bredt, Roger A Nicoll.   

Abstract

Trafficking of AMPA receptors (AMPA-Rs) to and from synapses controls the strength of excitatory synaptic transmission. However, proteins that cluster AMPA-Rs at synapses remain poorly understood. Here we show that PSD-95-like membrane-associated guanylate kinases (PSD-MAGUKs) mediate this synaptic targeting, and we uncover a remarkable functional redundancy within this protein family. By manipulating endogenous neuronal PSD-MAGUK levels, we find that both PSD-95 and PSD-93 independently mediate AMPA-R targeting at mature synapses. We also reveal unanticipated synapse heterogeneity as loss of either PSD-95 or PSD-93 silences largely nonoverlapping populations of excitatory synapses. In adult PSD-95 and PSD-93 double knockout animals, SAP-102 is upregulated and compensates for the loss of synaptic AMPA-Rs. At immature synapses, PSD-95 and PSD-93 play little role in synaptic AMPA-R clustering; instead, SAP-102 dominates. These studies establish a PSD-MAGUK-specific regulation of AMPA-R synaptic expression that establishes and maintains glutamatergic synaptic transmission in the mammalian central nervous system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046693     DOI: 10.1016/j.neuron.2006.09.012

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  200 in total

1.  AKAP79/150 impacts intrinsic excitability of hippocampal neurons through phospho-regulation of A-type K+ channel trafficking.

Authors:  Lin Lin; Wei Sun; Faith Kung; Mark L Dell'Acqua; Dax A Hoffman
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Activity-dependent regulation of synaptic strength by PSD-95 in CA1 neurons.

Authors:  Peng Zhang; John E Lisman
Journal:  J Neurophysiol       Date:  2011-11-23       Impact factor: 2.714

3.  Determinants of synaptic strength vary across an axon arbor.

Authors:  Xiaoyu Peng; Thomas D Parsons; Rita J Balice-Gordon
Journal:  J Neurophysiol       Date:  2012-01-25       Impact factor: 2.714

4.  The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo.

Authors:  Gilberto J Soler-Llavina; Marc V Fuccillo; Jaewon Ko; Thomas C Südhof; Robert C Malenka
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-27       Impact factor: 11.205

5.  Perisynaptic GluR2-lacking AMPA receptors control the reversibility of synaptic and spines modifications.

Authors:  Yunlei Yang; Xiao-Bin Wang; Qiang Zhou
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

6.  Ephrin-B3 recruits PSD-95 to synapses.

Authors:  Erkang Fei; Wen-Cheng Xiong; Lin Mei
Journal:  Nat Neurosci       Date:  2015-11       Impact factor: 24.884

7.  PSD-95 family MAGUKs are essential for anchoring AMPA and NMDA receptor complexes at the postsynaptic density.

Authors:  Xiaobing Chen; Jonathan M Levy; Austin Hou; Christine Winters; Rita Azzam; Alioscka A Sousa; Richard D Leapman; Roger A Nicoll; Thomas S Reese
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

8.  Agonist binding to the NMDA receptor drives movement of its cytoplasmic domain without ion flow.

Authors:  Kim Dore; Jonathan Aow; Roberto Malinow
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-09       Impact factor: 11.205

Review 9.  Mechanisms of postsynaptic localization of AMPA-type glutamate receptors and their regulation during long-term potentiation.

Authors:  Olivia R Buonarati; Erik A Hammes; Jake F Watson; Ingo H Greger; Johannes W Hell
Journal:  Sci Signal       Date:  2019-01-01       Impact factor: 8.192

Review 10.  Plasticity of dendritic spines: subcompartmentalization of signaling.

Authors:  Lesley A Colgan; Ryohei Yasuda
Journal:  Annu Rev Physiol       Date:  2013-11-06       Impact factor: 19.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.